National Heart Institute, Egypt Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2014
NCT02728518
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

National Heart Institute, Egypt